Trial Outcomes & Findings for Mobile Continuing Care Approach for Youth (NCT NCT01632735)

NCT ID: NCT01632735

Last Updated: 2015-08-21

Results Overview

Primary substance use relapse was measured by urine tests (0 = negative, 1 = positive).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

80 participants

Primary outcome timeframe

Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up

Results posted on

2015-08-21

Participant Flow

Participant milestones

Participant milestones
Measure
Mobile Continuing Care
Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support
Standard Continuing Care as Usual
Continuing care as usual (12-step facilitation) group
Overall Study
STARTED
40
40
Overall Study
COMPLETED
36
37
Overall Study
NOT COMPLETED
4
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Mobile Continuing Care Approach for Youth

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Mobile Continuing Care
n=40 Participants
Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support
Standard Continuing Care as Usual
n=40 Participants
Continuing care as usual (12-step facilitation) group
Total
n=80 Participants
Total of all reporting groups
Age, Continuous
22.1 years
STANDARD_DEVIATION 3.1 • n=5 Participants
19.0 years
STANDARD_DEVIATION 3.1 • n=7 Participants
20.4 years
STANDARD_DEVIATION 3.5 • n=5 Participants
Sex: Female, Male
Female
15 Participants
n=5 Participants
8 Participants
n=7 Participants
23 Participants
n=5 Participants
Sex: Female, Male
Male
25 Participants
n=5 Participants
32 Participants
n=7 Participants
57 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
10 Participants
n=5 Participants
20 Participants
n=7 Participants
30 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
30 Participants
n=5 Participants
20 Participants
n=7 Participants
50 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Asian
3 Participants
n=5 Participants
4 Participants
n=7 Participants
7 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
4 Participants
n=5 Participants
4 Participants
n=7 Participants
8 Participants
n=5 Participants
Race (NIH/OMB)
White
22 Participants
n=5 Participants
12 Participants
n=7 Participants
34 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
10 Participants
n=5 Participants
20 Participants
n=7 Participants
30 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
40 participants
n=5 Participants
40 participants
n=7 Participants
80 participants
n=5 Participants
education
14.0 years
STANDARD_DEVIATION 2.3 • n=5 Participants
12.0 years
STANDARD_DEVIATION 2.0 • n=7 Participants
12.9 years
STANDARD_DEVIATION 2.9 • n=5 Participants

PRIMARY outcome

Timeframe: Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up

Population: An intent to treat model was used. The primary outcome measure is primary substance use measured by urine drug test at baseline, discharge as well as at 3-, 6-, and 9-month follow-ups. Study retention at discharge was 95%, 92.5% at 3 months, 86.2% at 6 months, and 82.5% at 9 months.

Primary substance use relapse was measured by urine tests (0 = negative, 1 = positive).

Outcome measures

Outcome measures
Measure
Mobile Continuing Care
n=40 Participants
Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support
Standard Continuing Care as Usual
n=40 Participants
Continuing care as usual (12-step facilitation) group
Primary Substance Use (Defined as Substance Received Treatment for)
baseline substance use
47.5 percentage of positive urines
41.5 percentage of positive urines
Primary Substance Use (Defined as Substance Received Treatment for)
discharge substace use
14.7 percentage of positive urines
62.9 percentage of positive urines
Primary Substance Use (Defined as Substance Received Treatment for)
3-month follow-up substace use
21.4 percentage of positive urines
59.3 percentage of positive urines
Primary Substance Use (Defined as Substance Received Treatment for)
6-month follow-up substace use
16.7 percentage of positive urines
50.0 percentage of positive urines
Primary Substance Use (Defined as Substance Received Treatment for)
9-month follow-up substace use
11.1 percentage of positive urines
14.3 percentage of positive urines

SECONDARY outcome

Timeframe: baseline, discharge, 3-, 6- and 9-month follow-ups

Population: Intent to treatment model was used. Mixed modeling used to examine differences in recovery behaviors (measured by mean days doing extracurricular/recovery-goal directed activities) over time between study conditions.

Recovery behaviors defined as mean number of days doing extracurricular/recovery-goal directed activities using repeated measures over time.

Outcome measures

Outcome measures
Measure
Mobile Continuing Care
n=40 Participants
Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support
Standard Continuing Care as Usual
n=40 Participants
Continuing care as usual (12-step facilitation) group
Participation in Recovery Behaviors Over Time
baseline recovery behaviors
12.1 days per month
Standard Deviation 9.7
14.5 days per month
Standard Deviation 11.7
Participation in Recovery Behaviors Over Time
discharge recovery behaviors
17.3 days per month
Standard Deviation 8.5
10.3 days per month
Standard Deviation 11.4
Participation in Recovery Behaviors Over Time
3-month recovery behaviors
14.5 days per month
Standard Deviation 9.5
11.97 days per month
Standard Deviation 11.96
Participation in Recovery Behaviors Over Time
6-month recovery behaviors
17.5 days per month
Standard Deviation 10.6
13.8 days per month
Standard Deviation 12.9
Participation in Recovery Behaviors Over Time
9-month recovery behaviors
18.4 days per month
Standard Deviation 10.6
12.4 days per month
Standard Deviation 16.6

SECONDARY outcome

Timeframe: baseline, discharge, 3-, 6-, and 9-month follow-ups

Population: Used an intent to treat design. Examined the effects of the intervention (mobile continuing care) compared to aftercare as usual on change in recovery self-confidence over time.

Change/improvements in mean recovery confidence score over time (measured by question "How confident are you in your ability to be completely abstinent (clean) from alcohol and drugs in the next 30 days?" (units on scale included 0=not at all, 1=slightly, 2=moderately, 3=considerably, 4-extremely).

Outcome measures

Outcome measures
Measure
Mobile Continuing Care
n=40 Participants
Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support
Standard Continuing Care as Usual
n=40 Participants
Continuing care as usual (12-step facilitation) group
Recovery Confidence (Self-efficacy) Over Time
baseline confidence rating
2.40 units on a scale
Standard Deviation 1.3
2.53 units on a scale
Standard Deviation 1.2
Recovery Confidence (Self-efficacy) Over Time
discharge confidence rating
2.73 units on a scale
Standard Deviation 1.03
2.57 units on a scale
Standard Deviation 1.5
Recovery Confidence (Self-efficacy) Over Time
3-month follow-up confidence rating
2.67 units on a scale
Standard Deviation 1.3
2.43 units on a scale
Standard Deviation 1.4
Recovery Confidence (Self-efficacy) Over Time
6-month follow-up confidence rating
3.20 units on a scale
Standard Deviation 1.02
2.51 units on a scale
Standard Deviation 1.50
Recovery Confidence (Self-efficacy) Over Time
9-month follow-up confidence rating
2.85 units on a scale
Standard Deviation 1.3
2.73 units on a scale
Standard Deviation 1.3

SECONDARY outcome

Timeframe: Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up

Population: Intent to treat model was used to assess the effects of the intervention (mobile continuing care) compared to aftercare as usual in terms of improvements in social support service utilization over time (baseline, discharge and follow-ups: 3-, 6- and 9-months post-discharge).

Self-help utilization was measured by the question: "In the past 30 days, how many days did you attend self-help meetings like AA or NA to support your recovery?"

Outcome measures

Outcome measures
Measure
Mobile Continuing Care
n=40 Participants
Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support
Standard Continuing Care as Usual
n=40 Participants
Continuing care as usual (12-step facilitation) group
Social Support Utilization
9-month upport utilization
4.9 days per month
Standard Deviation 7.7
2.8 days per month
Standard Deviation 7.2
Social Support Utilization
baseline social support utilization
12.8 days per month
Standard Deviation 10.3
9.8 days per month
Standard Deviation 8.1
Social Support Utilization
discharge social support utilization
8.6 days per month
Standard Deviation 10.1
2.8 days per month
Standard Deviation 6.6
Social Support Utilization
3-month follow-up social support utilization
7.4 days per month
Standard Deviation 9.5
2.4 days per month
Standard Deviation 6.0
Social Support Utilization
6-month upport utilization
6.1 days per month
Standard Deviation 8.5
2.8 days per month
Standard Deviation 7.3

Adverse Events

Mobile Continuing Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard Continuing Care as Usual

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Rachel Gonzales Castaneda

Azusa Pacific University

Phone: 6268156000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place